↑ parent activity group ·
research dossier →

WATCHING OVER MOTHERS & BABIES
TUCSON, AZ · EIN 522420995 · Form 990 · FY2021 · NTEE E05 · Health Care · Small ($100K-$1M) · www.womb.org
revenue
$290K
expenses
$197K
net assets
$206K
employees
3
program ratio
95%
mission · from form 990

THE WATCHING OVER MOTHERS & BABIES FOUNDATION (WOMB) HELPS MOTHERS WITH PERINATAL HEALTH PROBLEMS AND IS PARTNERING WITH LOCAL AND NATIONAL ORGANIZATIONS TO ADDRESS A BROAD ARRAY OF PERINATAL HEALTH PROBLEMS.

profile · synthesized from sources

Watching Over Mothers & Babies (WOMB) is a research organization dedicated to improving maternal-child health through clinical research. It conducts studies with human subjects to find new ways to understand, detect, control, and treat illnesses affecting pregnant women, postpartum mothers, and newborns. WOMB partners with local and national organizations to address perinatal health problems.

named programs · 10 · from sources

what they call their work

AL29A
A study on the Tolerance of Infants Fed Milk-Based Infant formula with Oligosaccharides, sponsored by Abbott Nutrition.
AL30
A study sponsored by Abbott Nutrition.
AL33
A study on the Growth and Tolerance of Infants Fed Extensively Hydrolysate Formula Casein-Based Infant Formulas, sponsored by Abbott Nutrition.
ByHeart Formula
Evaluation of growth, safety, and efficacy of an infant formula for healthy term infants; Breastfeeding & Formula made by ByHeart.
CRB in PROM Patients (09-014)
A study sponsored by Cook Medical.
Family Alliance Intervention (FAM)
An intervention study by Watching Over Mothers & Babies (WOMB).
Pfizer RSV Vaccine C3671008 Phase 3
A Phase 3, Randomized, Double -or Observer-Blinded, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of a Respiratory Syncytial Virus (RSV) Prefusion F Subunit Vaccine in Infants Born to Women Vaccinated During Pregnancy.
Pivotal Study of the Rx AL-SENSE Liner
A prospective evaluation of a panty liner in pregnant women presenting to Labor & Delivery with complaints of leaking who were being evaluated for PROM, sponsored by Common Sense Inc.
RSV Vaccine in Pregnant Mothers (Pfizer C3671003)
A Phase 2b, Randomized, Placebo-Controlled, Observer-Blind study to Evaluate the Safety, Tolerability and Immunogenicity of a Respiratory Syncytial Virus (RSV) Vaccine with/without Aluminum in Healthy Second and Third-trimester Pregnant Women.
RSV-M-301
A study sponsored by Novavax Inc.
activities · 3 groups

what they do

  • Nutritional Research & Supplement Development 7 activities
    • Clinical Trials for Maternal and Infant Health
      Conducts Phase 2b and Phase 3 randomized, controlled, and blinded clinical trials to evaluate the efficacy, safety, tolerability, and immunogenicity of vaccines (e.g., RSV prefusion F subunit vaccine) in pregnant women and their infants, adhering to Good Clinical Practices and Federal Regulations.
    • Clinical research on maternal and infant health interventions
      Conducts clinical trials and research studies focused on improving maternal and child health, including vaccine efficacy, infant nutrition, and prenatal diagnostics, in compliance with Good Clinical Practices and Federal Regulations. Studies include Phase 2b and Phase 3 randomized, controlled trials involving pregnant women and infants.
    • Clinical trials on maternal and infant health interventions
      Conducts Phase 2b and Phase 3 randomized, placebo-controlled, observer-blinded clinical trials to evaluate the safety, immunogenicity, and efficacy of RSV vaccines administered during pregnancy to protect infants. Trials follow Good Clinical Practices and Federal Regulations.
    • Conducting clinical trials on maternal and infant health interventions
      Conducts clinical trials in accordance with Good Clinical Practices and Federal Regulations, focusing on interventions during pregnancy and infancy, including vaccines and infant feeding.
    • Infant Formula Research
      Conducts research evaluating the growth, safety, tolerance, and efficacy of various infant formulas, including extensively hydrolyzed casein-based formulas, milk-based formulas with oligosaccharides, and specific infant formulas for healthy term infants.
    • Infant formula tolerance and growth research
      Conducts research on the growth, safety, and tolerance of various infant formulas, including extensively hydrolyzed casein-based, milk-based with oligosaccharides, and commercial formulas like ByHeart, in healthy term infants.
    • Researching infant nutrition and formula tolerance
      Conducts research on the growth, safety, and tolerance of various infant formulas, including extensively hydrolyzed casein-based, milk-based with oligosaccharides, and formulas made by ByHeart, in healthy term infants.
  • Pregnancy Confirmation Services 1 activity
    • Premature Rupture of Membranes (PROM) Diagnostic Research
      Conducts prospective evaluations of diagnostic tools, such as panty liners, for pregnant women presenting with complaints of leaking to assess for premature rupture of membranes (PROM).
  • Uncategorized 7 activities
    • Family Alliance Intervention (FAM) Study
      Conducted the Family Alliance Intervention (FAM) study, with data analysis currently pending.
    • Implementing behavioral and family support studies during pregnancy and postpartum
      Conducted the Family Alliance Intervention (FAM) study, a behavioral intervention focused on family support during pregnancy and postpartum, with data analysis pending.
    • Intervention and behavioral health research
      Conducted the Family Alliance Intervention (FAM) study to evaluate a behavioral or psychosocial intervention, with data analysis currently pending.
    • Intervention and diagnostic evaluation studies in pregnancy
      Conducts research on maternal and infant health interventions, including the Family Alliance Intervention (FAM) study and prospective evaluation of a panty liner for detecting premature rupture of membranes (PROM) in pregnant women.
    • Reducing tobacco use during pregnancy and postpartum
      Conducted foundational research and interventions aimed at reducing and ceasing tobacco use and exposure during pregnancy and postpartum to improve maternal and child health outcomes.
    • Tobacco Cessation and Exposure Reduction Research
      Conducts foundational work focused on reducing and ceasing tobacco use and exposure during pregnancy and postpartum to improve maternal and child health outcomes.
    • Tobacco cessation programs during pregnancy and postpartum
      Conducted foundational work aimed at reducing and ceasing tobacco use and exposure during pregnancy and the postpartum period to improve maternal and child health outcomes.
financials · form 990 · fy2021
revenue
Total revenue$290K
Contributions & grants$00%
Program service revenue$290K100%
Investment income$40%
Other revenue$0
expenses
Total expenses$197K
Program expenses95%
Admin / overhead5%
Fundraising0%
Salaries & benefits$121K
Grants paid out$0
Largest expense lineCompensation
balance sheet
Total assets$210K
Cash$210K
Investments$0
Liabilities$4K
Net assets$206K
Liquid reserves12.7 mo
3 years on record · 2019–2021 · YoY revenue +109.3%
leadership · form 990 part vii · fy2021

who runs it

board members · 6
  • DR HUGH MILLER — PRESIDENT/CEO
  • DR MONICA CASPER — SECRETARY/TREASURER
  • KENNETH RAMOS — MEMBER
  • MICHELLE BROWN — COO/COUNSEL
  • PENNY BUSSEL-STANSFIELD — MEMBER
  • RALPH FREGOSI — MEMBER
relationships · 10

who they work with

  • Abbott Nutrition Funder — Sponsor of the AL33, AL29A, and AL30 studies.
  • ByHeart, Inc. Funder — Sponsor of the ByHeart Formula study.
  • Common Sense Inc. Funder — Sponsor of the Pivotal Study of the Rx AL-SENSE Liner.
  • Cook Medical Funder — Sponsor of the CRB in PROM Patients study.
  • FDA Government — Government authority that may review study patient records and information collected during studies.
  • FDA Government — Involved in monitoring studies through Investigational Review Boards, and sometimes directly involved in study design or ensuring safe conduct.
  • Novavax Inc. Funder — Sponsor of the RSV-M-301 study.
  • Pfizer Funder — Sponsor of the RSV Vaccine C3671008 Phase 3 study and the RSV Vaccine in Pregnant Mothers study.
  • basic scientists Partner — Builds partnerships with basic scientists in its quest to tackle clinical questions.
  • clinicians Partner — Builds partnerships with clinicians in its quest to tackle clinical questions.